1. Jeong, Hoe-Su, Jung, Eun-Shil, Sim, Ye-Ji, Kim, Chang-Hoon, Kim, Kye-Seong. 2015. Fbxo25 controls Tbx5 and Nkx2-5 transcriptional activity to regulate cardiomyocyte development. In Biochimica et biophysica acta, 1849, 709-21. doi:10.1016/j.bbagrm.2015.02.002. https://pubmed.ncbi.nlm.nih.gov/25725482/
2. Kuzmanov, Aleksandar, Johansen, Pål, Hofbauer, Günther. 2020. FBXO25 Promotes Cutaneous Squamous Cell Carcinoma Growth and Metastasis through Cyclin D1. In The Journal of investigative dermatology, 140, 2496-2504. doi:10.1016/j.jid.2020.04.003. https://pubmed.ncbi.nlm.nih.gov/32335130/
3. Jiang, Gui-Yang, Zhang, Xiu-Peng, Wang, Liang, Wang, En-Hua, Zhang, Yong. 2016. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 37, 14311-14319. doi:. https://pubmed.ncbi.nlm.nih.gov/27596142/
4. Baumann, Ursula, Fernández-Sáiz, Vanesa, Rudelius, Martina, Kuster, Bernhard, Bassermann, Florian. 2014. Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis. In Nature medicine, 20, 1401-9. doi:10.1038/nm.3740. https://pubmed.ncbi.nlm.nih.gov/25419709/
5. Jang, Jae-Woo, Lee, Won-Young, Lee, Jae-Ho, Kim, Chang-Hoon, Chung, Hyung-Min. 2011. A novel Fbxo25 acts as an E3 ligase for destructing cardiac specific transcription factors. In Biochemical and biophysical research communications, 410, 183-8. doi:10.1016/j.bbrc.2011.05.011. https://pubmed.ncbi.nlm.nih.gov/21596019/
智鼠故事 
